Formulation as a key differentiator in crowded therapeutic areas
Pharmaceutical markets are increasingly crowded with similar equipment, scientists, and facilities, which means differentiation is about more than the active…
Partner Content
-
-
Asia’s clinical research revolution: Why the world’s innovation centre is shifting east
The global map of clinical research is changing rapidly. Once viewed primarily as an attractive destination for cost-efficient clinical trials,…
-
Reaching maturity: A roadmap for Quality Excellence amid regulatory transformation
The regulatory landscape across life sciences has faced unprecedented shifts over the past year. Simultaneous realignments of FDA, EU, and…
-
Why your manufacturing floor is your greatest compliance risk – and opportunity
Ask any life sciences quality leader where their biggest compliance headaches originate, and you might expect them to point to…
-
Commercialising drugs in Europe: Lean models for first-time launchers
In 2025, 193 innovative drugs received approval in Europe, including 133 new molecular entities (NMEs). Over half – 56% -…
-
Lyophilisation is growing in pharma, but technical challenges persist
Lyophilisation, or freeze drying, is the process in which a liquid drug is converted into a stable powder via sublimation,…
-
China-ready by design: Leveraging NMPA’s new 30‑working day IND pathway
Over the last decade, China has become a key destination for oncology clinical trials, with Chinese sites increasingly incorporated within…
-
Why manual aseptic filling often provides faster start dates than automated lines
A Phase 1 start date may be tied to investor milestones. A rare disease therapy may represent a small patient…
-
Industry partnership will determine the success of the transition to low-GWP pMDIs
Opinion by Darren Bromley-Davenport, Technical Manager at Orbia Fluor & Energy Materials A tightening regulatory landscape is driving the pharmaceutical…
-
ADCs: How to manage complexities in growing supply chains
Upscaling the complex processes for bioconjugates manufacturing is now a necessity in the pharma industry as demand surges for innovative…